查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1134553

羟氯喹的全球市场:现状分析与预测(2022年～2028年)

Hydroxychloroquine Market: Current Analysis and Forecast (2022-2028)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 125 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球羟氯喹的市场规模在预测期间内预计将以约10％大幅度成长。市场增长可归因于发展中国家疟疾发病率的上升。

本报告提供全球羟氯喹市场相关调查分析，提供市场规模与预测分析，主要趋势和机会，企业简介等资讯。

目录

第1章 市场简介

第2章 调查手法·前提条件

第3章 市场摘要

第4章 摘要整理

第5章 羟氯喹市场上COVID-19的影响

第6章 羟氯喹的市场收益(2020年～2028年)

第7章 市场考察:各疾病

  • 疟疾
  • 类风湿性关节炎
  • COVID-19
  • 其他

第8章 市场考察:各驱动器类型

  • 医院药局
  • 零售药局
  • 线上药局

第9章 市场考察:各地区

  • 北美
    • 美国
    • 加拿大
    • 其他的北美
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他的欧洲
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他的亚太地区
  • 其他地区

第10章 羟氯喹的市场动态

  • 推动市场要素
  • 市场课题
  • 影响的分析

第11章 羟氯喹市场机会

第12章 羟氯喹市场趋势

第13章 供需分析

  • 需求端分析
  • 供应端分析

第14章 价值链分析

第15章 竞争模式

  • 竞争情形
    • 波特的五力分析

第16章 企业概要

  • Sanofi S.A.
  • Novartis AG
  • Pfizer Inc.
  • Cadila Pharmaceuticals Limited
  • Ipca Laboratories Limited
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Lupin Limited

第17章 免责声明

简介目录
Product Code: UMCH211107

Global Hydroxychloroquine Market is expected to grow at a significant rate of around 10% during the forecast period. Hydroxychloroquine is a medicine that is sold under the brand name Plaquenil and is used for preventing and treating malaria in areas where malaria remains sensitive to chloroquine. It is also used in the treatment of rheumatoid arthritis, lupus, COVID-19, etc. The growth of the hydroxychloroquine market can be attributed to the rising incidences of malaria in developing nations. For instance, according to the World Malaria Report, in 2019, nearly 6 million individuals were diagnosed with malaria alone in India. Also, as per WHO, in 2020, there were an estimated 241 million cases of malaria worldwide and the estimated number of malaria deaths stood at 6,27,000. Furthermore, many leading manufacturers of hydroxychloroquine have escalated the production and sales of this medicine during the pandemic as different studies in France & U.S. have shown promising results for the COVID-19 treatment.

Sanofi S.A., Novartis AG, Pfizer Inc., Cadila Pharmaceuticals Limited, Ipca Laboratories Limited, Mylan N.V., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Lupin Limited. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hydroxychloroquine.

 

Insights Presented in the Report:

"Amongst disease, malaria category to witness robust CAGR during the forecast period"

Based on disease, the market is segmented into malaria, rheumatoid arthritis, COVID-19, and others. The malaria segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe as hydroxychloroquine is an anti-malarial drug and is widely used for treating acute attacks of malaria. Furthermore, the surging cases of malaria across the world is also one of the prominent factors contributing to the growth of the market.

"Amongst distribution channels, the hospital pharmacy to hold a significant share in the market in 2020"

On the basis of distribution channels, the market is categorized into hospital pharmacies, retail pharmacies, and online pharmacies. Among these, the hospital pharmacies to hold a significant share in the market in 2020. This is mainly due to the increasing preference of the patients to avail treatment in hospitals and the easy availability of the medication in hospital pharmacies. However, the online pharmacy segment is expected to witness significant CAGR owing to the growing penetration of e-pharmacy platforms across the world coupled with increasing awareness regarding services offered by e-pharmacy.

"Asia-Pacific to hold a significant share in the market"

For a better understanding of the market adoption of the All-Terrain Vehicle industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. APAC is anticipated to grow at a substantial CAGR during the forecast period. This is mainly due to the increasing prevalence of malaria cases in developing Asian countries. Further, India is also one of the largest manufacturers and exporters of hydroxychloroquine which is also driving the market in the region.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

The global hydroxychloroquine market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Hydroxychloroquine Market
  • 2.2. Research Methodology of the Hydroxychloroquine Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE HYDROXYCHLOROQUINE MARKET

6 HYDROXYCHLOROQUINE MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY DISEASE

  • 7.1. Malaria
  • 7.2. Rheumatoid Arthritis
  • 7.3. COVID-19
  • 7.4. Others

8 MARKET INSIGHTS BY DRIVE TYPE

  • 8.1. Hospital Pharmacy
  • 8.2. Retail Pharmacy
  • 8.3. Online Pharmacy

9 MARKET INSIGHTS BY REGION

  • 9.1. North America
    • 9.1.1. U.S.
    • 9.1.2. Canada
    • 9.1.3. Rest of North America
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. U.K.
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Rest of Asia-Pacific
  • 9.4. Rest of World

10 HYDROXYCHLOROQUINE MARKET DYNAMICS

  • 10.1. Market Drivers
  • 10.2. Market Challenges
  • 10.3. Impact Analysis

11 HYDROXYCHLOROQUINE MARKET OPPORTUNITIES

12 HYDROXYCHLOROQUINE MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 13.1. Demand Side Analysis
  • 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 COMPETITIVE SCENARIO

  • 15.1. Competitive Landscape
    • 15.1.1. Porters Fiver Forces Analysis

16 COMPANY PROFILED

  • 16.1. Sanofi S.A.
  • 16.2. Novartis AG
  • 16.3. Pfizer Inc.
  • 16.4. Cadila Pharmaceuticals Limited
  • 16.5. Ipca Laboratories Limited
  • 16.6. Mylan N.V.
  • 16.7. Teva Pharmaceutical Industries Ltd.
  • 16.8. Torrent Pharmaceuticals Ltd.
  • 16.9. Sun Pharmaceutical Industries Ltd.
  • 16.10. Lupin Limited

17 DISCLAIMER